Board change at Biofusion

BIOFUSION, the Sheffield company that turns academic research into business, has announced that non-executive director Simon Oakland has stepped down from its board.

Mr Oakland has ceased to work for NPI Ventures Limited (NPI) – a technology investment businesss which works with Biofusion – and as a result will no longer serve on the board.

Jim Totty, NPI’s alternative representative to Biofusion, will continue to represent NPI at Biofusion’s board meetings.

Chief executive David Baynes, said: ‘We would like to thank Simon for his representation on the board of Biofusion since he joined in 2006. Simon, as a director of NPI Ventures, brought with him a wealth of corporate finance and investment experience and we wish him good luck for the future.’

Biofusion was established in 2002 to commercialise university-generated intellectual property.